Hysterectomy

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Exogenous Sex Hormones and PONV

Methylated Biomarkers Predictive of Endometrial Cancer Risk

Histerectomy Vs Partial Myometrial Resection for Placenta Accreta Spectrum

Conservative Management of Placenta Accreta Spectrum

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology

Quality of Life After Hysterectomy (AdenoQOL)

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis

Patient Centered Results for Uterine Fibroids

Inflammation and Cellular Immunity in Vaginal Tissue in Patients With Pelvic Organ Prolapse

Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia

Vaginal vs. Laparoscopic Hysterectomy